EDGAR Filing Documents for 0001493152-23-015169

Form DRS/A - Draft Registration Statement: [Amend]

SEC Accession No. 0001493152-23-015169

Filing Date

2023-05-02

Accepted

2023-05-02 15:12:55

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		filename1.htm	DRS/A	1731871
2		formdrsa_001.jpg	GRAPHIC	4134
3		formdra_007.jpg	GRAPHIC	44243
4		formdrsa_002.jpg	GRAPHIC	17600
5		formdra_008.jpg	GRAPHIC	93666
6		formdrsa_003.jpg	GRAPHIC	70751
7		formdrsa_004.jpg	GRAPHIC	6423
8		formdra_009.jpg	GRAPHIC	41668
9		image_001.jpg	GRAPHIC	29242
10		formdrsa_005.jpg	GRAPHIC	136980
11		formdrsa_006.jpg	GRAPHIC	149654
	Complete submission text file	0001493152-23-015169.txt		2552662

Mailing Address 324 SOUTH HYDE PARK AVENUE, SUITE 350 TAMPA FL 33606

Business Address 855 N WOLFE STREET #623-6 BALTIMORE MD 21205 813-369-5150

Mira1a Therapeutics, Inc. (Filer) CIK: 0001904286 (see all company filings)

IRS No.: 853354547 | State of Incorp.: FL
Type: DRS/A | Act: 33 | File No.: 377-06248 | Film No.: 23878405
SIC: 2834 Pharmaceutical Preparations